Cancer Control in Low-And Middle-Income Countries: Is It Time To Consider Screening? - Summary
Cancer Control in Low-And Middle-Income Countries: Is It Time To Consider Screening? - Summary
Cancer Control in Low-And Middle-Income Countries: Is It Time To Consider Screening? - Summary
2/17/2022
While not the face of disease for low-income countries, non-commutable disease has a
large impact on low-income countries. Non-commutable diseases have been on the rise globally
but have a larger prevalence and death rate for low-income countries. Over 50% of deaths in less
developed counties are considered premature. This impact substantially impacts the life span and
development of these countries. Countries with people dying prematurely have a difficult
creating and maintaining development. This is a global equity problem, and impacts women and
children more than any other demographic. This article from Heimburer et. Al describes the
devastating nature of cancers in less developed countries, details reasons for disparities, explains
The burden of cancers in less developed countries is steep. In 2018, there were 18.1
million new cancer diagnoses and 9.6 million deaths. These values are expected to only grow
higher. Despite having a lower incidence rate in comparison to high income countries, the high
mortality rate proves these commutable diseases to be dangerous. Within developed countries,
cancer rates appear to be stabilizing or decreasing, while in less developed countries cancer rates
are only increasing. This is for a few reasons, notably decreasing levels of smoking and
preventative measures in developed countries, and increased smoking and obesity within less
developed countries. Infection associated cancers are also much more prevalent in less developed
countries. These cancers are a very small percentage of cases in developed countries, while they
have a large impact in less developed countries. These high numbers and high death tolls might
not even be accurate. Diagnosing and detecting cancer is much less advanced in less developed
countries than in their developed counterparts. These trends are only expected to worsen as time
goes on.
Within the current healthcare systems that exist in less developed countries, they are not
designed to deal with non-commutable diseases. They have historically been built around
addressing nutrition, maternal heath, and commutable diseases, as these issues have been and
still are the biggest causes of mortality. The rise of non-commutable diseases poses a problem for
this system. This is complicated to fix and takes a variety of changes, including specific research
for the individual country, better systems of tracking cases, and screening. Comprehensive
changes in this health care system are a necessary step, but the high expenditure can be a
dissuading factor.
A huge way to change this trend of high mortality and minimal treatment in less
developed countries is with increased screening. According to the article, screening must be
“acceptable, sustainable, and economically efficient for the target population, and the health care
infrastructure must be equipped to manage the increased case finding with respect to treatment,
support, and follow up.” Improving health services, including increased cancer screenings is a
big step towards better cancer treatment and prevention. Screening has many different aspects to
consider. The reasoning behind screening is to detect cancers at a time when they can be treated
in ways possible in less developed countries. However, within less developed countries there are
unique risks. Cultural norms towards treatments and willingness towards treatment are both
obstacles. However, education on those of these topics can greatly help both issues.
uses three approaches- surgical resection, chemotherapy, and radiotherapy. All these treatments
are largely unavailable in less developed countries, despite a simple surgery sometimes being
enough to cure a deadly cancer. While these treatments have proven helpful for cancer treatment,
they are unavailable for the large part. Providing greater access to this care could have enormous
impacts on cancer treatment, but large-scale changes in healthcare need to be in place before
these changes can be made. Outside of these treatments, a different kind of treatment is
important. This is palliative care and pain control. As a result of many cancers being diagnosed
late and treatment being limited, pain control is an important treatment in improving quality of
life. Increasing pain treatment where it doesn’t exist currently can help people with cancer live a
better life for their time left. While this is not a life extending treatment, it is still an important
Investing in cancer screening, prevention, and control is a necessary step to fight against
increasing incidence and mortality of cancer in less developed countries. This can be seen in a
few ways, from prevention by eradicating bad behaviors such as smoking and obesity, to testing
and screening to higher technology treatments such as radiology. The treatment option available
might depend on the individual country and needs of that country. Cancer is very complex and
has several outcomes and treatments, and countries should create their own individual pathways